Lyell Immunopharma (LYEL) FCF Margin (2020 - 2026)
Lyell Immunopharma (LYEL) posted FCF Margin of -854450.00% for Q2 2026, down 421625.00 percentage points from -432825.00% a year earlier but up 1075500.00 percentage points from the prior quarter.
Lyell Immunopharma (LYEL) FCF Margin (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, FCF Margin at Lyell Immunopharma was -496188.89%, down 209527.22 percentage points year-over-year; for FY2025, it came in at -418900.00%, down 151919.67 percentage points from FY2024.
- Annual FCF Margin has declined for three consecutive years, with a five-year change of -416162.06 percentage points (FY2020 to FY2025).
- In prior years, Lyell Immunopharma's FCF Margin was -266980.33% in FY2024 (-138995.71 pp), -127984.62% in FY2023 (-127755.73 pp), -228.89% in FY2022 (+1571.61 pp) and -1800.50% in FY2021 (+937.45 pp).
- Quarterly FCF Margin has run from a low of -1929950.00% in Q1 2026 to a high of -92.69% in Q4 2022 over five years.
- On a year-over-year basis, FCF Margin has declined in each of the last five quarters, with an average year-over-year change of -169563.31 percentage points over the last eight quarters.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q3 2023, with a gain of 1178276.00 percentage points; the weakest was Q3 2022, with a drop of 1328453.68 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was -1929950.00% (Q1 2026), -542583.33% (Q4 2025) and -190926.67% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 30.39% |
| 10 | Lyell Immunopharma | 225.31 Mn | 225.31 Mn | - | -854,450.00% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -854,450.00% |
| Mar 31, 2026 | -1,929,950.00% |
| Dec 31, 2025 | -542,583.33% |
| Sep 30, 2025 | -190,926.67% |
| Jun 30, 2025 | -432,825.00% |
| Mar 31, 2025 | -785,485.71% |
| Dec 31, 2024 | -429,872.73% |
| Sep 30, 2024 | -103,238.24% |
| Jun 30, 2024 | -295,576.92% |
| Mar 31, 2024 | -1,401,533.33% |
| Dec 31, 2023 | -312,769.23% |
| Sep 30, 2023 | -151,524.00% |
| Jun 30, 2023 | -148,496.30% |
| Mar 31, 2023 | -73,453.85% |
| Dec 31, 2022 | -92.69% |
| Sep 30, 2022 | -1,329,800.00% |
| Jun 30, 2022 | -144.10% |
| Mar 31, 2022 | -10,413.20% |
| Dec 31, 2021 | -1,540.79% |
| Sep 30, 2021 | -1,346.32% |
Lyell Immunopharma FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();